4/A

FORM 4/A SUBMISSION

Company: Akebia Therapeutics, Inc.
Filed: January 5, 2015
Period of Report: December 23, 2014
Accession Number: 0001209191-15-000984

View Document ↗ View on SEC.gov ↗